Saliva Collection Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Saliva Collection Devices Market: By Product Type (Whole Saliva Collection Devices and Glandular Saliva Collection Devices), By Application (Pharma and Biotech Companies, Forensics, Dentistry, Diagnostic and Pathology Laboratories, and Research Institutes), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The saliva collection devices market is estimated to be valued at USD 263.3 million in 2021 at a CAGR of 12.9% over the forecast years (2022-2028). Increased approvals for saliva collection devices are expected to drive growth in the saliva collection devices market due to the growing need for rapid diagnosis of life-threatening diseases. Furthermore, technological advancements in infant saliva collection are expected to drive the growth of the saliva collection devices market. For example, Oasis Diagnostics created the Pedia SAL collection kit for infants. It enables saliva collection with the simplest design, with the goal of not only collecting saliva samples but also relaxing infants during the procedure. As the number of ailments increases, so will the number of clinical trials conducted by the government, creating new opportunities for the growth of the saliva collection devices market. The opportunity for point of care test kits is increasing due to mandating of drug abuse testing for employees, drivers, and person working at hazardous jobs. Development and launch of point-of-care test kits may enhance the revenue of market over the forecast timeframe. For instance, in January 2019, Alere received FDA 510(k) clearance of two new drug screening tests offer practitioner rapid, in-office results for the most abused opioid-derived drugs using urine sample. In the saliva collection devices market, the biotech companies segment expected to contribute the highest revenue share of 67.8% in 2021. The biotech companies’ rapid advancements and innovative technologies may boost the market.

Key Developments:

In Jan 2020, Salimetrics Introduced a New Salivary Human Total Immunoglobulin G (IgG) ELISA Kit to Aid Multidisciplinary Serological Researchers. The launch of this Salimetrics Salivary IgG Assay Kit is the result of extensive collaboration with public health researchers.

In Sept 2020, QIAGEN acquired NeuMoDx Molecular, Inc. The NeuMoDx systems full integration will enable QIAGEN to meet laboratory needs for molecular diagnostics in practically any situation.

Saliva Collection Devices Market

MARKET SUMMARY
-
12.9% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 12.9%
  • Fastest Growing Market– North America

Saliva Collection Devices Market

  • The report on global Saliva Collection Devices Market gives historical, current, and future market sizes (US$ Mn) on the basis of By Product Type, By End User and geography.
  • Saliva Collection Devices Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • OraSure Technologies
  • NEOGEN Corporation.
  • Oasis Diagnostics Corporation.
  • Salimetrics, LLC.
  • DiaMetra
Saliva Collection Devices Market

Dynamics

The prevalent rapid advancement occurring in healthcare, particularly in diagnostics and the emergence of new medical procedures and experimentations, are mainly responsible for leading the global saliva collection devices market. The high costs of setting up equipment required for carrying out quality and ethical saliva collection, as well as a lack of necessary expertise to carry out such activities in underdeveloped regions, are major impediments to the saliva collection devices market.


North-America Got Significant Share

Saliva Collection Devices Market

North America Saliva Collection Devices market held the highest market share of 32.3% in 2021. North America dominates the saliva test devices market due to the availability of necessary funds, mainly to conduct research and develop new and efficient treatments using clinical trials. Furthermore, the adoption of technologically advanced products and the growing number of regulatory agencies are driving the saliva collection devices market in North America to be the most lucrative. The Asia - Pacific is projected to have the largest increase in the market during the forecast period, owing to increased awareness for easy and safe diagnosis of various diseases through several symposiums and conferences held in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Key

Recent Market Developments:

Saliva Collection Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Abbott
  • NEOGEN Corporation.
  • Salimetrics, LLC.
  • Oasis Diagnostics Corporation.
  • DiaMetra
  • Isohelix
  • OraSure Technologies.
  • Candela Medical
  • Quest Diagnostics

Description

The saliva collection devices market is estimated to be valued at USD 263.3 million in 2021 at a CAGR of 12.9% over the forecast years (2022-2028). Increased approvals for saliva collection devices are expected to drive growth in the saliva collection devices market due to the growing need for rapid diagnosis of life-threatening diseases. Furthermore, technological advancements in infant saliva collection are expected to drive the growth of the saliva collection devices market. For example, Oasis Diagnostics created the Pedia SAL collection kit for infants. It enables saliva collection with the simplest design, with the goal of not only collecting saliva samples but also relaxing infants during the procedure. As the number of ailments increases, so will the number of clinical trials conducted by the government, creating new opportunities for the growth of the saliva collection devices market. The opportunity for point of care test kits is increasing due to mandating of drug abuse testing for employees, drivers, and person working at hazardous jobs. Development and launch of point-of-care test kits may enhance the revenue of market over the forecast timeframe. For instance, in January 2019, Alere received FDA 510(k) clearance of two new drug screening tests offer practitioner rapid, in-office results for the most abused opioid-derived drugs using urine sample. In the saliva collection devices market, the biotech companies segment expected to contribute the highest revenue share of 67.8% in 2021. The biotech companies’ rapid advancements and innovative technologies may boost the market.

Key Developments:

In Jan 2020, Salimetrics Introduced a New Salivary Human Total Immunoglobulin G (IgG) ELISA Kit to Aid Multidisciplinary Serological Researchers. The launch of this Salimetrics Salivary IgG Assay Kit is the result of extensive collaboration with public health researchers.

In Sept 2020, QIAGEN acquired NeuMoDx Molecular, Inc. The NeuMoDx systems full integration will enable QIAGEN to meet laboratory needs for molecular diagnostics in practically any situation.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX